Literature DB >> 10090197

Postmenopausal estrogen replacement therapy and risk of developing systemic lupus erythematosus or discoid lupus.

M Petri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090197

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  1 in total

1.  Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial.

Authors:  Robert Zimmer; Hugo R Scherbarth; Oscar Luis Rillo; Juan Jesus Gomez-Reino; Sylviane Muller
Journal:  Ann Rheum Dis       Date:  2012-11-21       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.